These findings suggest that PRL2 may play pleiotropic roles in tumorigenesis, acting as a driver of tumor progression and a marker of aggressiveness in certain tissues, while potentially suppressing tumor formation or growth in others. This evidence concerns the gene PTP4A2 and neoplasm.